Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Lung Cancer, Adjuvant Immunotherapy

Heather Wakelee

MD

🏢Stanford University Medical Center🌐USA

Chief, Division of Medical Oncology

58
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Heather Wakelee is chief of medical oncology at Stanford and a lead investigator in perioperative NSCLC trials. She was a principal investigator of IMpower010, which established atezolizumab as an adjuvant option for resected PD-L1-positive NSCLC. Her research has advanced understanding of optimal sequencing of chemotherapy, immunotherapy, and targeted agents in the perioperative setting for lung cancer.

Share:

🧪Research Fields 研究领域

adjuvant atezolizumab NSCLC IMpower010
perioperative NSCLC immunotherapy
resected NSCLC adjuvant therapy
osimertinib adjuvant EGFR
NSCLC disease-free survival endpoints

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Heather Wakelee 的研究动态

Follow Heather Wakelee's research updates

留下邮箱,当我们发布与 Heather Wakelee(Stanford University Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment